2022 Q1 Form 10-Q Financial Statement

#000156459022019334 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2020 Q4
Revenue $315.3M $219.8M $319.9M
YoY Change 43.45% 36.82% 48.17%
Cost Of Revenue $63.89M $50.50M $51.60M
YoY Change 26.51% 25.6% 9.09%
Gross Profit $251.4M $169.3M $268.3M
YoY Change 48.51% 40.55% 59.04%
Gross Profit Margin 79.74% 77.02% 83.87%
Selling, General & Admin $196.5M $107.6M $113.1M
YoY Change 82.59% 47.61% 35.94%
% of Gross Profit 78.15% 63.56% 42.15%
Research & Development $72.00M $53.92M $48.70M
YoY Change 33.53% 46.54% 48.48%
% of Gross Profit 28.64% 31.85% 18.15%
Depreciation & Amortization $12.35M $10.01M $7.800M
YoY Change 23.36% 54.56% 20.0%
% of Gross Profit 4.91% 5.91% 2.91%
Operating Expenses $268.5M $161.5M $161.9M
YoY Change 66.22% 339.0% 39.57%
Operating Profit -$17.05M $7.784M $106.4M
YoY Change -319.08% -27.7% 101.9%
Interest Expense -$281.0K $300.0K $500.0K
YoY Change -193.67% -400.0% -50.0%
% of Operating Profit 3.85% 0.47%
Other Income/Expense, Net -$281.0K $308.0K
YoY Change -191.23% -173.86%
Pretax Income -$17.33M $8.092M $107.0M
YoY Change -314.21% -21.81% 99.26%
Income Tax -$2.736M -$14.55M -$44.90M
% Of Pretax Income -179.81% -41.96%
Net Earnings -$14.60M $22.64M $151.9M
YoY Change -164.47% -5.88% 198.43%
Net Earnings / Revenue -4.63% 10.3% 47.48%
Basic Earnings Per Share -$0.03 $0.05
Diluted Earnings Per Share -$0.03 $0.05 $3.050M
COMMON SHARES
Basic Shares Outstanding 484.2M 472.8M
Diluted Shares Outstanding 484.2M 497.9M

Balance Sheet

Concept 2022 Q1 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.105B $680.1M $624.0M
YoY Change 62.41% 52.56% 144.71%
Cash & Equivalents $844.2M $471.6M $437.4M
Short-Term Investments $260.3M $208.4M $186.7M
Other Short-Term Assets $89.78M $121.4M $102.2M
YoY Change -26.04% 152.92% 266.31%
Inventory
Prepaid Expenses
Receivables $1.761B $1.369B $1.584B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.955B $2.170B $2.310B
YoY Change 36.18% 50.51% 59.42%
LONG-TERM ASSETS
Property, Plant & Equipment $359.6M $353.8M $115.9M
YoY Change 1.65% 26.76% 81.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $117.8M $78.70M $29.15M
YoY Change 49.62% 188.03% 26.05%
Total Long-Term Assets $477.4M $432.6M $443.3M
YoY Change 10.35% 32.94% 58.59%
TOTAL ASSETS
Total Short-Term Assets $2.955B $2.170B $2.310B
Total Long-Term Assets $477.4M $432.6M $443.3M
Total Assets $3.433B $2.603B $2.754B
YoY Change 31.89% 47.28% 59.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.406B $1.142B $1.348B
YoY Change 23.06% 72.19% 55.24%
Accrued Expenses $140.1M $121.2M $88.34M
YoY Change 15.62% 150.22% 87.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.546B $1.264B $1.475B
YoY Change 22.34% 72.05% 58.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $237.8M $254.9M $11.26M
YoY Change -6.7% 18.12% 2.34%
Total Long-Term Liabilities $237.8M $254.9M $11.26M
YoY Change -6.7% -28.96% 2.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.546B $1.264B $1.475B
Total Long-Term Liabilities $237.8M $254.9M $11.26M
Total Liabilities $1.784B $1.518B $1.741B
YoY Change 17.47% 38.89% 55.92%
SHAREHOLDERS EQUITY
Retained Earnings $474.4M
YoY Change 104.08%
Common Stock $538.8M
YoY Change 41.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.649B $1.084B $1.013B
YoY Change
Total Liabilities & Shareholders Equity $3.433B $2.603B $2.754B
YoY Change 31.89% 47.28% 59.28%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income -$14.60M $22.64M $151.9M
YoY Change -164.47% -5.88% 198.43%
Depreciation, Depletion And Amortization $12.35M $10.01M $7.800M
YoY Change 23.36% 54.56% 20.0%
Cash From Operating Activities $146.2M $75.07M $167.6M
YoY Change 94.74% 42.24% -696.44%
INVESTING ACTIVITIES
Capital Expenditures $8.401M $13.12M -$18.10M
YoY Change -35.97% -28.35% 19.87%
Acquisitions
YoY Change
Other Investing Activities -$57.09M -$22.10M -$64.40M
YoY Change 158.32% -731.43% 7950.0%
Cash From Investing Activities -$67.10M -$36.33M -$82.50M
YoY Change 84.72% 126.68% 418.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.98M -4.459M -82.10M
YoY Change -346.24% -102.83% -5573.33%
NET CHANGE
Cash From Operating Activities 146.2M 75.07M 167.6M
Cash From Investing Activities -67.10M -36.33M -82.50M
Cash From Financing Activities 10.98M -4.459M -82.10M
Net Change In Cash 90.07M 34.28M 3.000M
YoY Change 162.71% -82.36% -107.06%
FREE CASH FLOW
Cash From Operating Activities $146.2M $75.07M $167.6M
Capital Expenditures $8.401M $13.12M -$18.10M
Free Cash Flow $137.8M $61.95M $185.7M
YoY Change 122.42% 79.74% -1528.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70688000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55764000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71999000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53918000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
125799000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51845000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
332376000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
212027000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-17053000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7784000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-45000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
472816000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
52354000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
725000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
203000
CY2022Q1 ttd Noncash Lease Expense
NoncashLeaseExpense
10515000
CY2021Q1 ttd Noncash Lease Expense
NoncashLeaseExpense
9451000
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5304000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-998000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4905000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1013145000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12621000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52985000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1084313000
CY2022Q1 ttd Stock Issued During Period Value Restricted Stock Net Of Forfeitures And Shares Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockNetOfForfeituresAndSharesWithheldForTaxes
-13428000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
125415000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1649103000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-14598000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
22642000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12350000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10011000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
124895000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-259483000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-208847000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-23743000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16180000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-245937000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-200578000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8688000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5691000
CY2022Q1 ttd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-11990000
CY2021Q1 ttd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-10894000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
146192000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
75070000
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
121221000
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
89354000
CY2021Q1 ttd Proceeds From Sales Of Investments
ProceedsFromSalesOfInvestments
4539000
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
64133000
CY2021Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
62670000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8401000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13120000
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1614000
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1062000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67103000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36327000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24408000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12621000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13428000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17080000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10980000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4459000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
90069000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34284000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
754154000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
437353000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
844223000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
471637000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
14030000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
15107000
CY2021Q1 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
625000
CY2022Q1 ttd Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4732000
CY2021Q1 ttd Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-937000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1837000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2421000
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
520000
CY2021Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
631000
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note 1—Nature of Operations</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trade Desk, Inc. (the “Company”) is a global technology company that empowers buyers of advertising. Through the Company’s self-service, cloud-based platform, ad buyers can create, manage and optimize more expressive data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, native and social, on a multitude of devices, such as computers, mobile devices and connected TV (“CTV”). The Company’s platform integrations with major inventory, publisher and data partners provides ad buyers reach and decisioning capabilities, and the Company’s enterprise application programming interfaces (“APIs”) enable its clients to develop on top of the platform.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is a Delaware corporation formed in November 2009 and headquartered in Ventura, California with offices in various cities in North America, Europe, Asia and Australia.</p>
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management regularly evaluates its estimates, primarily those related to: (1) revenue recognition criteria, including the determination of revenue reporting as net versus gross in the Company’s revenue arrangements, (2) allowances for credit losses accounts, (3) operating lease assets and liabilities, including our incremental borrowing rate and terms and provisions of each lease (4) the useful lives of property and equipment and capitalized software development costs, (5) income taxes, (6) assumptions used in the option pricing models to determine the fair value of stock-based compensation and (7) the recognition and disclosure of contingent liabilities. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances; the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2022, the impact of the Coronavirus (“COVID-19”) pandemic on the Company’s business continues to evolve. As a result, many of the Company’s estimates and assumptions, including the allowance for credit losses, consider macro-economic factors in the market, which require increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, the Company’s estimates may change materially in future periods.</p>
CY2022Q1 ttd Common Stock Number Of Classes
CommonStockNumberOfClasses
2
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14598000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
484190000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
472816000
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25100000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
484190000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
497916000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25609000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
263000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
227934000
CY2022Q1 ttd Available For Sale Securities Debt Maturities With In One To Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithInOneToTwoYearsFairValue
32413000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
260347000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
12484000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
13095000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
472000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
171000
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1943000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1923000
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
626000
CY2021Q1 us-gaap Sublease Income
SubleaseIncome
650000
CY2022Q1 us-gaap Lease Cost
LeaseCost
14273000
CY2021Q1 us-gaap Lease Cost
LeaseCost
14539000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
124895000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
52354000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5597000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
51.54
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
884000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
77.10
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
518000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
40.20
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
266000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
57.35
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5697000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
56.27
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
26000000
CY2021Q1 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
26000000
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 ttd Number Of Business Activity
NumberOfBusinessActivity
1
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 ttd Billings Gross
BillingsGross
1
CY2021Q1 ttd Billings Gross
BillingsGross
1

Files In Submission

Name View Source Status
0001564590-22-019334-index-headers.html Edgar Link pending
0001564590-22-019334-index.html Edgar Link pending
0001564590-22-019334.txt Edgar Link pending
0001564590-22-019334-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ghsnsl10hjcl000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ttd-10q_20220331.htm Edgar Link pending
ttd-10q_20220331_htm.xml Edgar Link completed
ttd-20220331.xsd Edgar Link pending
ttd-20220331_cal.xml Edgar Link unprocessable
ttd-20220331_def.xml Edgar Link unprocessable
ttd-20220331_lab.xml Edgar Link unprocessable
ttd-20220331_pre.xml Edgar Link unprocessable
ttd-ex311_6.htm Edgar Link pending
ttd-ex312_8.htm Edgar Link pending
ttd-ex321_7.htm Edgar Link pending